The Daily Biotech Pulse: Eloxx Resumes Cystic Fibrosis Study, Rexahn’s Reverse Merger, Ultragenyx, Epizyme Await FDA Decisions Benzinga … Continue reading →
Form S-1/A Kaleyra, Inc. StreetInsider.com … Continue reading →
Form S-1/A Kaleyra, Inc. – StreetInsider.com Read More »
BRIEF-Iveric Bio Inc Announces Pricing Of Upsized Public Offering Of Common Stock at $4.100 Per Share Reuters … Continue reading →
Rexahn and Ocuphire Enter into Definitive Merger Agreement GlobeNewswire … Continue reading →
Rexahn and Ocuphire Enter into Definitive Merger Agreement – GlobeNewswire Read More »
VerifyMe Announces Pricing of $10.0 Million Public Offering, Uplisting to NASDAQ and 50-to-1 Reverse Stock Split Benzinga … Continue reading →
Brickell Biotech, Inc. Announces Pricing of $20.1 Million Underwritten Public Offering GlobeNewswire … Continue reading →
TSX Venture Exchange Stock Maintenance Bulletins Yahoo Finance … Continue reading →
TSX Venture Exchange Stock Maintenance Bulletins – Yahoo Finance Read More »
IT Tech Packaging : ITP Annual Report 2019.pdf Marketscreener.com … Continue reading →
IT Tech Packaging : ITP Annual Report 2019.pdf – Marketscreener.com Read More »
Pulse Biosciences, Inc. Announces Closing of $30 Million Rights Offering BioSpace … Continue reading →
Pulse Biosciences, Inc. Announces Closing of $30 Million Rights Offering – BioSpace Read More »
Form 4 Brigham Minerals, Inc. For: Jun 12 Filed by: WARBURG PINCUS LLC StreetInsider.com … Continue reading →
